SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-024661
Filing Date
2019-11-26
Accepted
2019-11-25 21:45:31
Documents
14
Period of Report
2019-11-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k112519b_alteritytherap.htm 6-K 13507
2 AGM PRESENTATION 2019 f6k112519bex99-1_alterity.htm EX-99.1 10785
3 GRAPHIC ex99-1_001.jpg GRAPHIC 77834
4 GRAPHIC ex99-1_002.jpg GRAPHIC 215219
5 GRAPHIC ex99-1_003.jpg GRAPHIC 184071
6 GRAPHIC ex99-1_004.jpg GRAPHIC 171709
7 GRAPHIC ex99-1_005.jpg GRAPHIC 176302
8 GRAPHIC ex99-1_006.jpg GRAPHIC 236996
9 GRAPHIC ex99-1_007.jpg GRAPHIC 151855
10 GRAPHIC ex99-1_008.jpg GRAPHIC 101706
11 GRAPHIC ex99-1_009.jpg GRAPHIC 209810
12 GRAPHIC ex99-1_010.jpg GRAPHIC 159761
13 GRAPHIC ex99-1_011.jpg GRAPHIC 176655
14 GRAPHIC ex99-1_012.jpg GRAPHIC 54377
  Complete submission text file 0001213900-19-024661.txt   2291035
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 191247503
SIC: 2834 Pharmaceutical Preparations